O. Tofanetti

852 total citations
35 papers, 749 citations indexed

About

O. Tofanetti is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, O. Tofanetti has authored 35 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Pharmacology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in O. Tofanetti's work include Analytical Methods in Pharmaceuticals (4 papers), Chemotherapy-induced organ toxicity mitigation (4 papers) and Metabolism and Genetic Disorders (3 papers). O. Tofanetti is often cited by papers focused on Analytical Methods in Pharmaceuticals (4 papers), Chemotherapy-induced organ toxicity mitigation (4 papers) and Metabolism and Genetic Disorders (3 papers). O. Tofanetti collaborates with scholars based in Italy and United States. O. Tofanetti's co-authors include D Castoldi, Egidio A. Moja, Ennio Cavalletti, Franco Zunino, Graziella Pratesi, F. Sala, V. Monzani, A. Pinelli, David M. Stoff and Renzo Colombo and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Hepatology and Biochemical Pharmacology.

In The Last Decade

O. Tofanetti

35 papers receiving 698 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Tofanetti Italy 14 146 139 121 118 113 35 749
W. Kochen Germany 14 107 0.7× 208 1.5× 47 0.4× 36 0.3× 39 0.3× 37 928
D. Esposti Italy 19 149 1.0× 286 2.1× 42 0.3× 46 0.4× 82 0.7× 30 1.3k
C. John Parli United States 15 105 0.7× 155 1.1× 36 0.3× 57 0.5× 77 0.7× 30 513
Shen‐Nan Lin United States 16 154 1.1× 173 1.2× 75 0.6× 34 0.3× 43 0.4× 21 776
P. R. Bieck Germany 19 320 2.2× 238 1.7× 24 0.2× 92 0.8× 310 2.7× 73 1.2k
Jonathan M. Oyler United States 19 420 2.9× 372 2.7× 96 0.8× 54 0.5× 243 2.2× 31 1.5k
Morris D. Faiman United States 22 270 1.8× 354 2.5× 367 3.0× 37 0.3× 66 0.6× 63 1.3k
Haig Bozigian United States 23 103 0.7× 213 1.5× 17 0.1× 88 0.7× 70 0.6× 40 1.1k
Terry D. Lindstrom United States 14 327 2.2× 245 1.8× 26 0.2× 97 0.8× 218 1.9× 43 979
John Jonsson Sweden 17 350 2.4× 292 2.1× 52 0.4× 25 0.2× 136 1.2× 41 880

Countries citing papers authored by O. Tofanetti

Since Specialization
Citations

This map shows the geographic impact of O. Tofanetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Tofanetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Tofanetti more than expected).

Fields of papers citing papers by O. Tofanetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Tofanetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Tofanetti. The network helps show where O. Tofanetti may publish in the future.

Co-authorship network of co-authors of O. Tofanetti

This figure shows the co-authorship network connecting the top 25 collaborators of O. Tofanetti. A scholar is included among the top collaborators of O. Tofanetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Tofanetti. O. Tofanetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeneroli, Maria Luisa, et al.. (1991). Alterations of GABA-A and dopamine D-2 brain receptors in dogs with portal-systemic encephalopathy. Life Sciences. 48(1). 37–50. 25 indexed citations
2.
Facino, Roberto Maffei, et al.. (1990). Antihepatotoxic properties of uridine-diphosphoglucose in liver fluke infection. Experimental fascioliasis in the rat.. PubMed. 40(4). 490–8. 3 indexed citations
3.
Cignarella, Giorgio, Daniela Barlocco, Gérard A. Pinna, et al.. (1989). Synthesis and biological evaluation of substituted benzo[h]cinnolinones and 3H-benzo[6,7]cyclohepta[1,2-c]pyridazinones: higher homologs of the antihypertensive and antithrombotic 5H-indeno[1,2-c]pyridazinones. Journal of Medicinal Chemistry. 32(10). 2277–2282. 30 indexed citations
4.
Moja, Egidio A., et al.. (1989). Dose-response decrease in plasma tryptophan and in brain tryptophan and serotonin after tryptophan-free amino acid mixtures in rats. Life Sciences. 44(14). 971–976. 138 indexed citations
5.
Zunino, Franco, et al.. (1989). Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug. Chemico-Biological Interactions. 70(1-2). 89–101. 144 indexed citations
6.
Facino, Roberto Maffei, et al.. (1989). Participation of lipid peroxidation in the loss of hepatic drug-metabolizing activities in experimental fascioliasis in the rat. Pharmacological Research. 21(5). 549–560. 24 indexed citations
7.
Facino, Roberto Maffei, M. Carini, & O. Tofanetti. (1988). Carboxylic metabolites of tiadenol as “proximate” inducers of hepatic peroxisomal β-oxidation activity. Pharmacological Research Communications. 20(4). 265–276. 8 indexed citations
8.
Pinelli, A., et al.. (1988). Anti-convulsant effects by reduced glutathione and related aminoacids in rats treated with isoniazid. Toxicology. 48(1). 103–107. 4 indexed citations
9.
Borghi, Alessandro, et al.. (1988). BBR 2173, a new non narcotic antitussive agent. Pharmacological Research Communications. 20. 171–171. 5 indexed citations
10.
Castoldi, D, V. Monzani, & O. Tofanetti. (1988). Simultaneous determination of nimesulide and hydroxynimesulide in human plasma and urine by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 425(2). 413–418. 41 indexed citations
11.
Moja, Egidio A., et al.. (1988). Decrease in plasma tryptophan after tryptophan-free amino acid mixtures in man. Life Sciences. 42(16). 1551–1556. 76 indexed citations
12.
Tofanetti, O., et al.. (1985). Prevention of cyclophosphamide-induced urotoxicity by reduced glutathione and its effect on acute toxicity and antitumor activity of the alkylating agent. Cancer Chemotherapy and Pharmacology. 14(3). 188–93. 15 indexed citations
13.
Zecca, Luigi, Silvio Trivulzio, A. Pinelli, Renzo Colombo, & O. Tofanetti. (1985). Determination of glibenclamide, chlorpropamide and tolbutamide in plasma by high-performance liquid chromatography with ultraviolet detection. Journal of Chromatography B Biomedical Sciences and Applications. 339(1). 203–209. 30 indexed citations
14.
Pinelli, A., et al.. (1984). Inhibitory effects of 2-guanidinebenzimidazole and 1-phenylbiguanide on gastric acid secretion in rats.. PubMed. 34(8). 890–4. 3 indexed citations
15.
Zunino, Franco, et al.. (1983). Protective Effect of Reduced Glutathione against CIS-Dichlorodiammine Platinum (II)–Induced Nephrotoxicity and Lethal Toxicity. Tumori Journal. 69(2). 105–111. 36 indexed citations
16.
Facino, Roberto Maffei, M. Carini, M.L. Nava, & O. Tofanetti. (1983). Effects of chronic tiadenol administration on liver microsomal cytochrome P-450 and associated monooxygenases in the rat.. PubMed. 38(12). 429–38. 1 indexed citations
17.
Carini, M., et al.. (1981). “In vitro” metabolism of Bezafibrate by rat liver. Pharmacological Research Communications. 13(2). 121–132. 6 indexed citations
18.
19.
Castoldi, D & O. Tofanetti. (1979). Gas chromatographic determination of glibenclamide in plasma. Clinica Chimica Acta. 93(2). 195–198. 23 indexed citations
20.
Bossa, R, et al.. (1976). Effect of various anti-tumor drugs on energetic processes. Pharmacological Research Communications. 8(4). 369–377. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. Kochen Breakdown of academic impact, for papers by D. Esposti Breakdown of academic impact, for papers by C. John Parli Breakdown of academic impact, for papers by Shen‐Nan Lin Breakdown of academic impact, for papers by P. R. Bieck Breakdown of academic impact, for papers by Jonathan M. Oyler Breakdown of academic impact, for papers by Morris D. Faiman Breakdown of academic impact, for papers by Haig Bozigian Breakdown of academic impact, for papers by Terry D. Lindstrom Breakdown of academic impact, for papers by John Jonsson
Rankless by CCL
2026